HWM
TXG icon

Hemington Wealth Management’s 10x Genomics TXG Stock Holding History

Hemington Wealth Management’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-149
Closed -$2K – 1756
2024
Q4 		$2K Buy
149
+129
+645% +$2.04K ﹤0.01% 1333
2024
Q3 		$0 Buy
+20
New +$413 ﹤0.01% 1744

Other funds holding TXG

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Hemington Wealth Management's TXG Position: Q1 2025 in Review

Hemington Wealth Management sold out of 10x Genomics (TXG) in Q1 2025, closing a stake of 149 shares — an estimated $2K sold.

Hemington Wealth Management first reported a position in TXG in Q3 2024 and held it in 2 quarters. The position peaked at $2K in Q4 2024. 274 funds tracked by Wall St. Rank hold TXG as of Q1 2025.

  • Hemington Wealth Management reported no remaining 10x Genomics position as of Q1 2025 after selling out during the quarter.
  • Hemington Wealth Management sold 149 10x Genomics shares in Q1 2025, an estimated $2K.
  • Hemington Wealth Management first reported a position in 10x Genomics in Q3 2024 and held it in 2 quarters.
  • Hemington Wealth Management's 10x Genomics position peaked at $2K in Q4 2024.
  • 274 funds tracked by Wall St. Rank held 10x Genomics as of Q1 2025.

Based on Hemington Wealth Management's 13F filing for Q1 2025, filed 9 May 2025.